Antiviral drugs

The use of antiviral medications significantly lowers the risk of hospitalization and death caused by Covid-19 among older patients, according to a Greek study.

Ljubljana – The anti-viral drug molnupiravir will be available for treatment of Covid-19 in Slovenia expectedly from Monday after doses for over 5,700 treatments have already arrived in the country. The medicine will be prescribed to adults, except pregnant women and breastfeeding mothers, who are likely to develop a severe form of Covid-19.

Ljubljana – Slovenia’s national medical ethics committee has no reservations towards Lagevrio, a medicine also known as molnupiravir. The committee maintains that the drug brings significant progress in fighting the coronavirus epidemic, as it prevents a severe course of Covid-19 or death.

Updated data from the experimental pill for the treatment of COVID-19 by the American company Merck & Co show that its effectiveness is significantly lower than the original report. According to preliminary data from October, "molnupiravir" reduces the risk of death and hospitalization by 50%.

Breakthrough in drugs against COVID-19 by oral administration, in tablet form. At this stage we have two such molecules - one is molnupiravir, the other ritonavir. This was commented in "The day begins" Prof. Ilko Getov, Bulgarian representative in the European Medicines Agency.

Clinical trials have been conducted that show the drugs have excellent efficacy, he said.

Pfizer UK managing director Ben Osborne said on Tuesday that the pharmaceutical company's Covid-19 drug, Paxlovid, could be available in the UK "very early in 2022".

Meanwhile, Merck's coronavirus pill, Molnupiravir, will be released as part of a UK trial in late November.

The easy-to-administer treatment has halved the risk of hospitalization or death from Covid-19 for people with mild to moderate symptoms

Ljubljana

The combination of two antibody treatments, casirivimab and imdevimab, is used at the request of attending physicians and at the patient’s responsibility since it currently has a temporary permit from the Slovenian Agency for Medicinal Products and Medical Devices, the Health Ministry said on Tuesday.

As Poonam Sinha fought for her life, her distraught son found himself fending off black marketeers for coronavirus drugs after the Indian hospital treating her ran out of supplies.

Preliminary testing shows that 29 out of 30 virus patients in serious condition that were administered the drug, made a full recovery in five days